Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Pratik K. Thakkar"'
Autor:
E. Merinopoulou, Nafeesa N. Dhalwani, Fei Yang, AP Cox, Robert Carroll, Sreeram V Ramagopalan, Pratik K. Thakkar, Laura McDonald, B. Malcolm, Faisal Mehmud, Mustafa Oguz
Publikováno v:
Future Oncology. 15:3763-3774
Aim: To identify the difference in physical activity (PA) levels between individuals with and without cancer, and to estimate all-cause mortality associated with this difference. Methods: Current cancer, cancer survivor and cancer-free groups were id
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f94e2b7da29eec93f9d965a534b8405
https://doi.org/10.2217/fon-2019-0443
https://doi.org/10.2217/fon-2019-0443
Autor:
M.S. Fazeli, H.A. Tawbi, D. Pushkarna, Nicolas Meyer, Pratik K. Thakkar, B. Breznen, Dirk Schadendorf, C. Vyas, Srividya Kotapati, Andriy Moshyk, L. Leung, Georgina V. Long
Publikováno v:
Annals of Oncology. 32:S892-S893
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1be3353e970401b7398a45021e02afac
https://doi.org/10.1016/j.annonc.2021.08.1462
https://doi.org/10.1016/j.annonc.2021.08.1462
Autor:
Helen Gogas, Christine Yip, Paolo A. Ascierto, Julia Braverman, Maurice Lobo, James Larkin, Fiona Taylor, Jeffrey S. Weber, Pratik K. Thakkar, Xiaowu Sun, Andriy Moshyk
Publikováno v:
Journal of Clinical Oncology. 39:9574-9574
9574 Background: In CheckMate 238, NIVO 3 mg/kg vs ipilimumab 10 mg/kg showed significantly longer recurrence-free survival and a lower rate of grade 3–4 treatment-related adverse events (TRAEs) in pts with completely resected stage IIIB/C or IV me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5270f0493adcda5be0077fee266fa503
https://doi.org/10.1200/jco.2021.39.15_suppl.9574
https://doi.org/10.1200/jco.2021.39.15_suppl.9574